Grace Wood
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Student
Also affiliated: Iowa State University (2024)
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Grace Wood's research focuses on disease mechanisms and health outcomes, particularly in preclinical models of metabolic disorders. Her work has investigated the renoprotective effects of interventions like resistant starch and renin-angiotensin system inhibitors in type 2 diabetes models, examining their impact on vitamin D homeostasis and proteinuria. Additionally, her research has explored factors influencing waitlist outcomes for individuals with metabolic-associated steatotic liver disease, specifically how menopausal status modifies these results under MELD 3.0 allocation.
Wood collaborates with researchers from the University of Arkansas for Medical Sciences and the University of Arkansas at Little Rock. Her scholarly contributions include two publications, with her most recent work published in 2026.
Metrics
- Publications: 2
Positions
-
Student publications 2026University of Arkansas for Medical Sciences College of Medicine ORCID
Selected Publications
-
Menopausal status modifies waitlist outcomes in women with metabolic-associated steatotic liver disease under MELD 3.0 allocation (2026)
Collaboration Network
Top Collaborators
- Menopausal status modifies waitlist outcomes in women with metabolic-associated steatotic liver disease under MELD 3.0 allocation
- Menopausal status modifies waitlist outcomes in women with metabolic-associated steatotic liver disease under MELD 3.0 allocation
- Menopausal status modifies waitlist outcomes in women with metabolic-associated steatotic liver disease under MELD 3.0 allocation
- Menopausal status modifies waitlist outcomes in women with metabolic-associated steatotic liver disease under MELD 3.0 allocation
- Menopausal status modifies waitlist outcomes in women with metabolic-associated steatotic liver disease under MELD 3.0 allocation
Similar Researchers
Based on overlapping research topics